VEGFA and pancreatic adenocarcinoma: The results from the present study demonstrate that, despite variability between eligible studies as to the relative prognostic impact of VEGF expression in resected pancreatic adenocarcinoma, the observed survival trend is concordant with that reported for other malignancies in similar meta-analyses (Delmotte et al, 2002; Kyzas et al, 2005a, 2005b; Des Guetz et al, 2006).